The Board of Directors has approved the
appointment of a new auditing supervisor
Date of events
2022/03/25
To which item it meets
paragraph 8
Statement
1.Type of personnel changed (please enter:
spokesperson, acting spokesperson, important
personnel (CEO, COO, CMO, CSO, etc.), financial
officer, accounting officer, corporate governance
officer, research and development officer, internal
audit officer, or designated and non-designated
representatives):internal auditing supervisor
2.Date of occurrence of the change:2022/03/25
3.Name, title, and resume of the previous position holder:Not applicable
4.Name, title, and resume of the new position holder:
Pei YU Yeh / Internal auditing supervisor
5.Type of change (please enter: "resignation",
"position adjustment", "dismissal", "retirement",
"death" or "new replacement"):New appointment
6.Reason for the change:
The Board of Directors has approved the appointment of a new auditing
supervisor
7.Effective date:2022/03/25
8.Any other matters that need to be specified:None
Attachments
Original Link
Original Document
Permalink
Disclaimer
ShareHope Medicine Co. Ltd. published this content on 25 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 March 2022 06:45:10 UTC.
ShareHope Medicine Co., Ltd. is principally engaged in the supply of pharmaceuticals, medical materials and technology materials. The Company is also engaged in the provision of medical health check and medical testing laboratories management consulting and entrusted operation services, the leasing of equipment and the provision of long-term care services. The Company operates its business through five segments: pharmaceutical distribution, health management, technology materials, hospitals and others. The Company distributes its products within domestic market and to overseas markets.
SHAREHOPE MEDICINE CO., LTD. 
